Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

[Anti-suicidal effect of lithium: current state of research and its clinical implications for the long-term treatment of affective disorders].

Lewitzka U, Bauer M, Felber W, Müller-Oerlinghausen B.

Nervenarzt. 2013 Mar;84(3):294-306. doi: 10.1007/s00115-012-3542-5. Review. German.

PMID:
22528065
2.

The suicide prevention effect of lithium: more than 20 years of evidence-a narrative review.

Lewitzka U, Severus E, Bauer R, Ritter P, Müller-Oerlinghausen B, Bauer M.

Int J Bipolar Disord. 2015 Dec;3(1):32. doi: 10.1186/s40345-015-0032-2. Epub 2015 Jul 18.

3.

Pharmacological prevention of suicide in patients with major mood disorders.

Rihmer Z, Gonda X.

Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 1):2398-403. doi: 10.1016/j.neubiorev.2012.09.009. Epub 2012 Sep 27. Review.

PMID:
23022665
4.

Effects of medical interventions on suicidal behavior. Summary and conclusions.

Baldessarini RJ, Jamison KR.

J Clin Psychiatry. 1999;60 Suppl 2:117-22.

5.

[Pharmacological suicide prevention under special consideration of lithium salts].

Müller-Oerlinghausen B.

Psychiatr Prax. 2007 Sep;34 Suppl 3:S292-5. Review. German.

PMID:
17786886
6.

Length of lithium treatment needed to eliminate the high mortality of affective disorders.

Ahrens B, Müller-Oerlinghausen B, Grof P.

Br J Psychiatry Suppl. 1993 Sep;(21):27-9.

PMID:
8217064
7.

Suicidal behavior and prophylactic lithium treatment of major mood disorders: a review of reviews.

Schou M.

Suicide Life Threat Behav. 2000 Fall;30(3):289-93. Review.

PMID:
11079641
8.

Lithium treatment and suicide risk in major affective disorders: update and new findings.

Baldessarini RJ, Tondo L, Hennen J.

J Clin Psychiatry. 2003;64 Suppl 5:44-52. Review.

9.

Lithium reduces pathological aggression and suicidality: a mini-review.

Müller-Oerlinghausen B, Lewitzka U.

Neuropsychobiology. 2010;62(1):43-9. doi: 10.1159/000314309. Epub 2010 May 7. Review.

PMID:
20453534
10.

Lithium for maintenance treatment of mood disorders.

Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G.

Cochrane Database Syst Rev. 2001;(3):CD003013. Review.

PMID:
11687035
11.

Lithium for maintenance treatment of mood disorders.

Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G.

Cochrane Database Syst Rev. 2001;(2):CD003013. Review. Update in: Cochrane Database Syst Rev. 2001;(3):CD003013.

PMID:
11406061
12.

Effect of lithium maintenance on suicidal behavior in major mood disorders.

Tondo L, Jamison KR, Baldessarini RJ.

Ann N Y Acad Sci. 1997 Dec 29;836:339-51. Review.

PMID:
9616808
13.

The role of psychopharmacology in suicide prevention.

Saunders KE, Hawton K.

Epidemiol Psichiatr Soc. 2009 Jul-Sep;18(3):172-8.

PMID:
20034192
14.

Lithium, anticonvulsants and suicidal behavior in bipolar disorder.

Yerevanian BI, Koek RJ, Mintz J.

J Affect Disord. 2003 Feb;73(3):223-8.

PMID:
12547290
15.

Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial.

Girlanda F, Cipriani A, Agrimi E, Appino MG, Barichello A, Beneduce R, Bighelli I, Bisoffi G, Bisogno A, Bortolaso P, Boso M, Calandra C, Cascone L, Castellazzi M, Corbascio C, Parise VF, Gardellin F, Gennaro D, Hanife B, Lintas C, Lorusso M, Luca A, Luca M, Luchetta C, Lucii C, Maio F, Marsilio A, Mattei C, Moretti D, Nosè M, Occhionero G, Papanti D, Pecile D, Percudani M, Prestia D, Purgato M, Restaino F, Romeo S, Sciarma T, Strizzolo S, Tamborini S, Todarello O, Tozzi F, Ziero S, Zotos S, Barbui C.

BMC Res Notes. 2014 Oct 17;7:731. doi: 10.1186/1756-0500-7-731.

16.

The antisuicidal and mortality-reducing effect of lithium prophylaxis: consequences for guidelines in clinical psychiatry.

Müller-Oerlinghausen B, Berghöfer A, Ahrens B.

Can J Psychiatry. 2003 Aug;48(7):433-9. Review.

PMID:
12971012
17.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
18.

Heterogeneity of the risk of suicidal behavior in bipolar-spectrum disorders.

Cavazzoni P, Grof P, Duffy A, Grof E, Müller-Oerlinghausen B, Berghöfer A, Ahrens B, Zvolsky P, Robertson C, Davis A, Hajek T, Alda M.

Bipolar Disord. 2007 Jun;9(4):377-85.

PMID:
17547584
19.

[Psychopharmaceuticals for treatment of suicidal patients and for suicide prevention].

Haußmann R, Bauer M, Lewitzka U, Müller-Oerlinghausen B.

Nervenarzt. 2016 May;87(5):483-7. doi: 10.1007/s00115-016-0088-y. Review. German.

PMID:
26952239
20.

Antidepressants and suicidal risk.

Müller-Oerlinghausen B, Berghöfer A.

J Clin Psychiatry. 1999;60 Suppl 2:94-9; discussion 111-6. Review.

Supplemental Content

Support Center